Normal-But-Low Serum Folate Levels and the Risks for Cognitive Impairment.
Cognition
Cohort studies
Dementia
Elderly
Folate
Longitudinal studies
Journal
Psychiatry investigation
ISSN: 1738-3684
Titre abrégé: Psychiatry Investig
Pays: Korea (South)
ID NLM: 101242994
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
04
03
2019
accepted:
29
05
2019
entrez:
30
7
2019
pubmed:
30
7
2019
medline:
30
7
2019
Statut:
ppublish
Résumé
This study aimed to examine the association between normal-but-low folate levels and cognitive function in the elderly population using a prospective cohort study. We analyzed 3,910 participants whose serum folate levels were within the normal reference range (1.5-16.9 ng/mL) at baseline evaluation in the population-based prospective cohort study named the "Korean Longitudinal Study on Cognitive Aging and Dementia." The association between baseline folate quartile categories and baseline cognitive disorders [mild cognitive impairment (MCI) or dementia] was examined using binary logistic regression analysis adjusting for confounding variables. The risks of incident MCI and dementia associated with the decline of serum folate level during a 4-year follow-up period were examined using multinomial logistic regression analysis. The lowest quartile group of serum folate (≥1.5, ≤5.9 ng/mL) showed a higher risk of cognitive disorders than did the highest quartile group at baseline evaluation (odds ratio 1.314, p=0.012). Over the 4 years of follow-up, the risk of incident dementia was 2.364 times higher among subjects whose serum folate levels declined from the 2nd-4th quartile group to the 1st quartile than among those for whom it did not (p=0.031). Normal-but-low serum folate levels were associated with the risk of cognitive disorders in the elderly population, and a decline to normal-but-low serum folate levels was associated with incident dementia. Maintaining serum folate concentration above 5.9 ng/mL may be beneficial for cognitive status.
Identifiants
pubmed: 31352735
pii: pi.2019.05.29
doi: 10.30773/pi.2019.05.29
pmc: PMC6664218
doi:
Types de publication
Journal Article
Langues
eng
Pagination
532-538Subventions
Organisme : Ministry of Health and Welfare
ID : HI09C1379
Références
Arch Neurol. 1999 Mar;56(3):303-8
pubmed: 10190820
J Gerontol B Psychol Sci Soc Sci. 2002 Jan;57(1):P47-53
pubmed: 11773223
J Neurosci. 2002 Mar 1;22(5):1752-62
pubmed: 11880504
BMJ. 2002 Nov 23;325(7374):1202
pubmed: 12446535
J Int Neuropsychol Soc. 2004 Jan;10(1):72-81
pubmed: 14751009
Am J Clin Nutr. 2004 Jul;80(1):114-22
pubmed: 15213037
J Intern Med. 2004 Sep;256(3):240-6
pubmed: 15324367
J Psychosom Res. 2004 Sep;57(3):297-305
pubmed: 15507257
Arch Neurol. 2005 Apr;62(4):641-5
pubmed: 15824266
Am J Clin Nutr. 2005 Sep;82(3):636-43
pubmed: 16155278
Ann Neurol. 2005 Dec;58(6):847-57
pubmed: 16254972
Lancet. 2005 Dec 17;366(9503):2112-7
pubmed: 16360788
Lancet Neurol. 2006 Nov;5(11):949-60
pubmed: 17052662
J Neurol Neurosurg Psychiatry. 2008 Aug;79(8):864-8
pubmed: 18252751
Dement Geriatr Cogn Disord. 2010;29(4):363-70
pubmed: 20424455
Psychiatry Investig. 2010 Jun;7(2):102-8
pubmed: 20577618
Future Neurol. 2010 Jul 1;5(4):501-517
pubmed: 20856693
J Alzheimers Dis. 2013;33(4):1097-104
pubmed: 23099812
Adv Nutr. 2012 Nov 01;3(6):801-12
pubmed: 23153734
J Intern Med. 2014 Mar;275(3):214-28
pubmed: 24605806
BMC Public Health. 2014 Jun 24;14:643
pubmed: 24962204
JAMA Intern Med. 2014 Oct;174(10):1696-7
pubmed: 25111789
J Alzheimers Dis. 2015;46(3):777-90
pubmed: 25854931
Alzheimers Dement. 2016 Apr;12(4):459-509
pubmed: 27570871
Nutr Res Pract. 2018 Feb;12(1):47-51
pubmed: 29399296
Alzheimers Res Ther. 2018 May 24;10(1):50
pubmed: 29793529
Psychiatry Investig. 2018 Aug;15(8):767-774
pubmed: 30086611
Hematol Transfus Cell Ther. 2018 Oct-Dec;40(4):305-309
pubmed: 30370407
Annu Rev Nutr. 1985;5:115-41
pubmed: 3927946
Lancet. 1970 Jan 10;1(7637):61-3
pubmed: 4188624
Eur J Clin Nutr. 1997 Nov;51 Suppl 3:S46-50
pubmed: 9598768
Arch Neurol. 1998 Nov;55(11):1449-55
pubmed: 9823829